Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients.

Trial Profile

Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Mar 2012

At a glance

  • Drugs Rivastigmine (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Mar 2012 Actual end date Mar 2012 added as reported by ClinicalTrials.gov.
    • 19 Mar 2012 Actual initiation date changed from Jun 2010 to Jul 2010 as reported by ClinicalTrials.gov.
    • 19 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top